NCT00003294View on ClinicalTrials.gov

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 1997

Primary Completion Date

April 30, 1999

Study Completion Date

May 31, 2004

Conditions
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

filgrastim

DRUG

amifostine trihydrate

DRUG

carboplatin

DRUG

paclitaxel

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER